{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:21:31Z","timestamp":1773642091866,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/s0169-2607(02)00120-7","type":"journal-article","created":{"date-parts":[[2003,1,17]],"date-time":"2003-01-17T12:34:03Z","timestamp":1042806843000},"page":"117-125","source":"Crossref","is-referenced-by-count":31,"title":["Software to compute and conduct sequential Bayesian phase I or II dose-ranging clinical trials with stopping rules"],"prefix":"10.1016","volume":"72","author":[{"given":"Sarah","family":"Zohar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelien","family":"Latouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Taconnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0169-2607(02)00120-7_BIB1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/2531628","article-title":"Continual reassessment method: a practical design for phase I clinical trials in cancer","volume":"46","author":"O'Quigley","year":"1990","journal-title":"Biometrics"},{"key":"10.1016\/S0169-2607(02)00120-7_BIB2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/sim.4780101104","article-title":"Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study","volume":"10","author":"O'Quigley","year":"1991","journal-title":"Stat. Med."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/sim.4780121201","article-title":"The continual reassessment method in cancer phase I clinical trials: a simulation study","volume":"12","author":"Chevret","year":"1993","journal-title":"Stat. Med."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10543409408835079","article-title":"Practical modifications of the continual reassessment method for phase I cancer clinical trials","volume":"4","author":"Faries","year":"1994","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB5","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/sim.4780131802","article-title":"A comparison of two phase I trial designs","volume":"13","author":"Korn","year":"1994","journal-title":"Stat. Med."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/sim.4780141102","article-title":"Some practical improvements in the continual reassessment method for phase I studies","volume":"14","author":"Goodman","year":"1995","journal-title":"Stat. Med."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/sim.4780140909","article-title":"An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses","volume":"14","author":"Moller","year":"1995","journal-title":"Stat. Med."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1537::AID-SIM872>3.0.CO;2-F","article-title":"An evaluation of phase I cancer clinical trial designs","volume":"17","author":"Ahn","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s002800050763","article-title":"Practical implementation of a modified continual reassessment method for dose-finding trials","volume":"41","author":"Piantadosi","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB10","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/sim.920","article-title":"The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies","volume":"20","author":"Zohar","year":"2001","journal-title":"Stat. Med."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0169-2607(94)90099-X","article-title":"Integral evaluation for continual reassessment method","volume":"42","author":"Bensadon","year":"1994","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/S0169-2607(02)00120-7_BIB12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2307\/2534012","article-title":"A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I\/II clinical trials","volume":"54","author":"Thall","year":"1998","journal-title":"Biometrics"},{"key":"10.1016\/S0169-2607(02)00120-7_BIB13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/biomet\/85.3.741","article-title":"Stopping rule for the continual reassessment method","volume":"85","author":"O'Quigley","year":"1998","journal-title":"Biometrika"},{"key":"10.1016\/S0169-2607(02)00120-7_BIB14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2307\/2532905","article-title":"Continual reassessment method: a likelihood approach","volume":"52","author":"O'Quigley","year":"1996","journal-title":"Biometrics"},{"key":"10.1016\/S0169-2607(02)00120-7_BIB15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2125.1998.00788.x","article-title":"An approach for dose finding of drugs in infants: sedation by midazolam studied using the continual reassessment method","volume":"46","author":"Fabre","year":"1998","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260702001207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260702001207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T07:58:50Z","timestamp":1553932730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260702001207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0169260702001207"],"URL":"https:\/\/doi.org\/10.1016\/s0169-2607(02)00120-7","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}